Penumbra, Inc. to Present at Upcoming Investor Conferences
Penumbra (NYSE: PEN) has announced its upcoming participation in two major healthcare investor conferences. The company will present at the 2025 Wells Fargo Healthcare Conference on September 3, 2025, at 8:45 AM ET, and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9, 2025, at 1:50 PM ET.
Investors can access the presentation webcasts through Penumbra's website in the "Events and Presentations" section under the "Investors" tab. The recordings will remain available for a minimum of two weeks after each event.
Penumbra (NYSE: PEN) annuncia la partecipazione a due importanti conferenze per investitori nel settore sanitario. L'azienda presenterà al 2025 Wells Fargo Healthcare Conference il 3 settembre 2025 alle 08:45 ET e al Morgan Stanley 23rd Annual Global Healthcare Conference il 9 settembre 2025 alle 13:50 ET.
Gli investitori potranno seguire le webcast delle presentazioni sul sito di Penumbra, nella sezione "Eventi e Presentazioni" sotto la scheda "Investitori". Le registrazioni resteranno disponibili per almeno due settimane dopo ciascun evento.
Penumbra (NYSE: PEN) ha anunciado su participación en dos importantes conferencias para inversores del sector salud. La compañÃa presentará en la 2025 Wells Fargo Healthcare Conference el 3 de septiembre de 2025 a las 08:45 ET y en la Morgan Stanley 23rd Annual Global Healthcare Conference el 9 de septiembre de 2025 a la 13:50 ET.
Los inversores podrán acceder a las retransmisiones de las presentaciones en la web de Penumbra, en la sección "Eventos y Presentaciones" dentro de la pestaña "Inversores". Las grabaciones estarán disponibles como mÃnimo durante dos semanas después de cada evento.
Penumbra (NYSE: PEN)ê°€ 주요 헬스케ì–� 투ìžìž� 컨í¼ëŸ°ìФ ë‘� ê³³ì— ì°¸ê°€í•� ì˜ˆì •ì´ë¼ê³� 발표했습니다. 회사ëŠ� 2025 Wells Fargo Healthcare Conferenceì—서 2025ë…� 9ì›� 3ì� ì˜¤ì „ 8ì‹� 45ë¶�(ET)ì—�, Morgan Stanley 23rd Annual Global Healthcare Conferenceì—서 2025ë…� 9ì›� 9ì� 오후 1ì‹� 50ë¶�(ET)ì—� 발표ë¥� 진행합니ë‹�.
투ìžìžë“¤ì€ Penumbra 웹사ì´íЏì� "ì´ë²¤íŠ� ë°� í”„ë ˆì í…Œì´ì…˜" 섹션("투ìžìž�" íƒ�)ì—서 í”„ë ˆì í…Œì´ì…˜ 웹ìºìŠ¤íŠ¸ë¥� 시ì²í•� ìˆ� 있습니다. ê°� ì´ë²¤íŠ� í›� 녹화 ì˜ìƒì€ 최소 2주간 ì œê³µë©ë‹ˆë‹�.
Penumbra (NYSE: PEN) a annoncé sa participation à deux grandes conférences pour investisseurs dans le secteur de la santé. La société présentera lors de la 2025 Wells Fargo Healthcare Conference le 3 septembre 2025 à 08h45 ET et lors de la Morgan Stanley 23rd Annual Global Healthcare Conference le 9 septembre 2025 à 13h50 ET.
Les investisseurs pourront accéder aux webcasts des présentations sur le site de Penumbra, dans la section « Événements et Présentations » sous l'onglet « Investisseurs ». Les enregistrements resteront disponibles pendant au moins deux semaines après chaque événement.
Penumbra (NYSE: PEN) hat seine Teilnahme an zwei wichtigen Healthcare-Investorenkonferenzen angekündigt. Das Unternehmen wird auf der 2025 Wells Fargo Healthcare Conference am 3. September 2025 um 08:45 Uhr ET und auf der Morgan Stanley 23rd Annual Global Healthcare Conference am 9. September 2025 um 13:50 Uhr ET präsentieren.
Investoren können die Webcasts der Präsentationen auf der Penumbra-Website in der Rubrik "Veranstaltungen und Präsentationen" unter dem Reiter "Investoren" abrufen. Die Aufzeichnungen sind jeweils mindestens zwei Wochen nach dem Event verfügbar.
- None.
- None.
Event: | Â 2025 Wells Fargo Healthcare Conference |
Date: | Â Wednesday, September 3, 2025 |
Time: | 8:45am ET/5:45am PT |
Event: | Morgan Stanley 23rd Annual Global Healthcare Conference |
Date: | Â Tuesday, September 9, 2025 |
Time: | Â 1:50pm ET/10:50am PT |
Webcasts of the presentations can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at . The webcasts will be available on the company's website for at least two weeks following each event.
About PenumbraÂ
Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit and connect on , and .
Investor Relations
Penumbra, Inc.
[email protected]
View original content to download multimedia:
SOURCE Penumbra, Inc.